Insufficient scRNA-seq data for expression of NPY2R at single-cell level.
Insufficient scRNA-seq data for expression of NPY2R at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 92% | 293.39 | 422 / 459 | 10% | 1.17 | 117 / 1118 |
brain | 57% | 106.33 | 1507 / 2642 | 31% | 1.52 | 216 / 705 |
intestine | 76% | 48.65 | 735 / 966 | 0% | 0.01 | 2 / 527 |
blood vessel | 66% | 58.90 | 877 / 1335 | 0% | 0 | 0 / 0 |
skin | 34% | 22.17 | 608 / 1809 | 1% | 0.01 | 3 / 472 |
adipose | 32% | 33.79 | 391 / 1204 | 0% | 0 | 0 / 0 |
ovary | 16% | 10.52 | 28 / 180 | 11% | 0.31 | 46 / 430 |
adrenal gland | 4% | 1.38 | 10 / 258 | 22% | 6.02 | 50 / 230 |
prostate | 15% | 7.42 | 36 / 245 | 6% | 0.24 | 31 / 502 |
stomach | 19% | 6.87 | 68 / 359 | 1% | 0.02 | 4 / 286 |
esophagus | 12% | 4.07 | 170 / 1445 | 0% | 0 | 0 / 183 |
kidney | 11% | 4.03 | 10 / 89 | 0% | 0.01 | 2 / 901 |
spleen | 7% | 1.83 | 17 / 241 | 0% | 0 | 0 / 0 |
thymus | 5% | 1.64 | 32 / 653 | 1% | 0.03 | 6 / 605 |
bladder | 5% | 0.76 | 1 / 21 | 0% | 0.00 | 1 / 504 |
heart | 5% | 1.30 | 39 / 861 | 0% | 0 | 0 / 0 |
lung | 4% | 1.29 | 23 / 578 | 1% | 0.01 | 6 / 1155 |
uterus | 1% | 0.32 | 1 / 170 | 3% | 0.13 | 12 / 459 |
liver | 1% | 0.24 | 2 / 226 | 0% | 0.01 | 1 / 406 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.01 | 1 / 178 |
muscle | 0% | 0.17 | 4 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007218 | Biological process | neuropeptide signaling pathway |
GO_0003151 | Biological process | outflow tract morphogenesis |
GO_0003214 | Biological process | cardiac left ventricle morphogenesis |
GO_0007193 | Biological process | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
GO_0007626 | Biological process | locomotory behavior |
GO_0005929 | Cellular component | cilium |
GO_0097730 | Cellular component | non-motile cilium |
GO_0005886 | Cellular component | plasma membrane |
GO_0005246 | Molecular function | calcium channel regulator activity |
GO_0001601 | Molecular function | peptide YY receptor activity |
GO_0038023 | Molecular function | signaling receptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0004983 | Molecular function | neuropeptide Y receptor activity |
Gene name | NPY2R |
Protein name | Neuropeptide Y receptor type 2 (NPY2-R) (NPY-Y2 receptor) (Y2 receptor) |
Synonyms | |
Description | FUNCTION: Receptor for neuropeptide Y and peptide YY. The rank order of affinity of this receptor for pancreatic polypeptides is PYY > NPY > PYY (3-36) > NPY (2-36) > [Ile-31, Gln-34] PP > [Leu-31, Pro-34] NPY > PP, [Pro-34] PYY and NPY free acid. |
Accessions | P49146 ENST00000329476.4 ENST00000506608.1 |